Three Peptides From the Atrial Natriuretic Factor Prohormone Amino Terminus Lower Blood Pressure and Produce Diuresis, Natriuresis, and/or Kaliuresis in Humans
暂无分享,去创建一个
D. Schocken | D. vesely | W. Gower | J. Dietz | M. Mccormick | M. A. Douglass | G. Rodriguez-Paz | D. Vesely
[1] F. Friedl,et al. Atrial natriuretic peptides in the heart and hemolymph of the oyster, Crassostrea virginica: a comparison with vertebrates. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.
[2] B. Brenner,et al. Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2. , 1992, The Journal of clinical investigation.
[3] B. Ackerman,et al. Pharmacokinetic Characterization of the Postdistribution Phase of Prohormone Atrial Natriuretic Peptides Amino Acids 1–98, 31–67, and Atrial Natriuretic Factor During and After Rapid Right Ventricular Pacing in Dogs , 1992, Journal of clinical pharmacology.
[4] D. vesely,et al. Specific binding site for pro atrial natriuretic factors 1-30, 31-67, and 99-126 on distal nephrons, proximal tubules, renal cortical and medullary membranes. , 1992, Renal physiology and biochemistry.
[5] D. vesely,et al. Release of ANF, proANF 1-98, and proANF 31-67 from isolated rat atria by atrial distension. , 1991, The American journal of physiology.
[6] D. Martin,et al. Three peptides from the ANF prohormone NH(2)-terminus are natriuretic and/or kaliuretic. , 1990, The American journal of physiology.
[7] V. Catanzarite,et al. Increase in the plasma levels of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during normal pregnancy. , 1990 .
[8] D. vesely,et al. Specific binding sites for prohormone atrial natriuretic peptides 1–30, 31–67 and 99–126 , 1990, Peptides.
[9] P. Norsk,et al. Increased Release of the N-Terminal and C-Terminal Portions of the Prohormone of Atrial Natriuretic Factor During Immersion-Induced Central Hypervolemia in Normal Humans 1 , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[10] S. Bloom,et al. Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. , 1988, British heart journal.
[11] J. Sundsfjord,et al. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. , 1988, The Journal of clinical endocrinology and metabolism.
[12] H. Itoh,et al. Secretion of N‐Terminal Fragment of γ‐Human Atrial Natriuretic Polypeptide , 1988 .
[13] D. vesely,et al. Two new hormones: prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man. , 1988, Biochemical and biophysical research communications.
[14] H. J. Kramer,et al. Atrial natriuretic hormones. , 1988, General pharmacology.
[15] D. vesely,et al. Circadian rhythm of prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126 in man. , 1988, Chronobiology international.
[16] D. A. Baeyens,et al. Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta. , 1987, Biochemical and biophysical research communications.
[17] D. vesely,et al. Human prepro atrial natriuretic factors 26-55, 56-92, and 104-123 increase renal guanylate cyclase activity. , 1987, Biochemical and biophysical research communications.
[18] M. Cantin,et al. Atrial natriuretic factor and urinary kallikrein in the rat: antagonistic factors? , 1984, Canadian journal of physiology and pharmacology.
[19] J. Laragh,et al. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility. , 1984, Hypertension.
[20] M. Currie,et al. Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. , 1983, Science.
[21] A. D. de Bold,et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.